Home / Products / Vagitocin®

Vagitocin® – clinical development on hold

Vagitocin® is a developmental pharmaceutical preparation for the treatment of vaginal atrophy. The product is based on oxytocin, a natural substance, which is produced in the body and that has been used to promote labour and breast-feeding since the beginning of the 1960ies.

Local application of Vagitocin® in the vagina has been shown to rejuvenate the vaginal mucosa. Vagitocin® is in clinical development phase 2. However, the development of Vagitocin® has been put on hold until a better understanding of its mechanism of action has been gained.

Learn more about oxytocin, vaginal atrophy and clinical development.

 

NOTE! Vagitocin® is not yet approved as a drug
 

All press releases on Spotlightstockmarket.com

All published press releases from PEPTONIC medical is available on spotlightstockmarket.com.

Contact us

Please contact us if you would like to know more about PEPTONIC medical or Vagivital™.

Contacts »